Evaluation of the cost-saving potential of a generic dispensing incentive program

Drug Benefit Trends

Volumn 16, Issue 10, 2004, Pages 515-524

  Hong, Song Hee ^a   Canterbury, Norman F ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Arkansas BlueCross BlueShield ^*  (United States)

Author keywords

Drug costs; Generic Dispensing Incentive Program; Generic dispensing rate

Indexed keywords

GENERIC DRUG;

COST CONTROL; COST EFFECTIVENESS ANALYSIS; DISEASE MANAGEMENT; DRUG COST; EVALUATION; GENERIC DISPENSING INCENTIVE PROGRAM; HEALTH CARE FINANCING; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; PRESCRIPTION; REIMBURSEMENT; REVIEW;

EID: 7444243224     PISSN: 10805826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Levit K, Smith C, Cowan C, et al. Trends in US health care spending, 2001. Health Aff (Millwood). 2003;22:154-164.
2. Levit K, Smith C, Cowan C, et al. Health spending rebound continues in 2002. Health Aff (Millwood). 2004;23:147-159.
3. Heffler S, Smith S, Keehan S, et al. Health spending projections through 2013. Health Aff Web Exclusive. February 11, 2004. Available at: http://content.healthaffairs.org/cgi/content/full/hlthaff.w4.79v1/DC1. Accessed September 1, 2004.
4. FDA Center for Drug Evaluation and Research. FDA ensures equivalence of generic drugs. Rockville, Md: US Food and Drug Administration; 2002. Available at: www.fda.gov/cder/about/whatwedo/testtube-17.pdf. Accessed September 1, 2004.
5. Sipkoff M. HMOs pushing generics with sundry incentives. Drug Topics. 2004;148(generic suppl 1):18s.
6. Covington TR. Generic drug utilization: corner-stone of value. Birmingham Business Journal. February 10, 2003. Available at: www.bizjournals.com/ birmingham/stories/2003/02/10/focus6.html. Accessed September 1, 2004.
7. Fisher JP. With expiration of patents, generic drugs get boost. The Detroit News. August 28, 2003. Available at: www.detnews.com/2003/health/0308/ 28/a14d-256441.htm. Accessed September 1, 2004.
8. Joyce GF, Escarce JJ, Solomon MD, Goldman DP. Employer drug benefit plans and spending on prescription drugs. JAMA. 2002;288:1733-1739.
9. Watson T. Strategies for maximizing generic opportunities in payer populations. Drag Cost Manage Report. August 8, 2003.
10. Health plans, PBMs reap big savings through tried-and-true generic programs. Drug Cost Manage Report. May 14, 2004.
11. Highmark and Trigon boost use of generic drugs for Medicare members. Drug Cost Manage Report. June 2002.
12. WellPoint launches GenericSelect program; health insurer to emphasize generic alternatives that empower members and help them control out-of-pocket costs. Business Wire. January 6, 2003.
13. Glover L. Highmark pilots program to promote generic drugs. Pittsburgh Business Times. October 3, 2003. Available at: http://Pittsburgh.bizjournals. com/pittsburgh/stories/2003/10/06/story4.html. Accessed September 1, 2004.
14. Rundle RL. California health plans offer coupons to buy generic drugs. Wall Street Journal. September 15, 2003.
15. Keating EJ. Maximizing generic substitution in managed care. J Managed Care Pharm. 1998;4:557-563.
16. Drug Trend Report: Featuring the Pharmacy Benefit Guide. 8th ed. St Louis: Express Scripts; 2004.
17. Study reveals: physicians are prescribing more generics first. Medco Health Solutions, Inc. January 2, 2002. Available at www.medco.com. Accessed September 1, 2004.
18. Mott D, Cline RR. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Medical Care. 2002;40:662-674.
19. SAS Systems for Windows. Gary, NC: SAS Institute, Inc; 2001.
20. Kreling DH. Cost control for prescription drug programs: pharmacy benefit manager (PBM) efforts, effects, and implications. August 8, 2000. Available at: http://aspe.os.dhhs.gov/health/reports/Drug-papers/Kreling-Final.htm. Accessed September 1, 2004.
21. Kreling DH, Mott DA, Wiederholt JB, et al. Prescription Drug Trends - A Chartbook Update. Menlo Park, Calif: Kaiser Family Foundation; 2001.
22. Zoeller J. Generic rates rise. Am Druggist. 1998;215:47.